NIH-funded research R01 grant

Investigating brainstem dysfunction and inflammation in sudden infant death syndrome (SIDS)

Official title: Inflammatory stressors in serotonergic brainstem dysfunction and SIDS

Funded at Boston Children's Hospital · NIH-11058431 · Data updated 2026-11-12

This study is looking into how certain brain issues might make babies more vulnerable to sudden infant death syndrome (SIDS) and how things like low oxygen or infections could make it worse, with the hope of finding ways to reduce the risk of SIDS.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2023
Project endMarch 31, 2027
Funding year2025
Award (this year)$723,152
NIH project number5R01HD107060-03
Project IDNIH-11058431 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include infants at risk for SIDS, particularly those with a family history or exposure to known risk factors.

Less likely to help

Patients who are older children or adults, or those without any risk factors for SIDS, may not benefit from this research.

What this research studies

This research focuses on understanding the biological vulnerabilities associated with sudden infant death syndrome (SIDS) by examining serotonergic dysfunction in the brainstem. It aims to identify how external stressors, such as hypoxia and infections, may exacerbate these vulnerabilities and lead to SIDS. By analyzing tissue samples and using animal models, the study seeks to uncover potential biomarkers and preventative strategies that could help reduce the risk of SIDS. The findings may provide insights into the neuroinflammatory processes that contribute to this condition.

Why it matters

Potential benefit: If successful, this research could lead to new preventative measures and interventions that significantly reduce the incidence of SIDS.

How similar studies have gone: Previous research has shown promising results in understanding the role of neuroinflammation and serotonergic dysfunction in SIDS, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Boston Children's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Haynes, Robin Lynn — Boston Children's Hospital
  • Study coordinator: Haynes, Robin Lynn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.